Torax Medical's Linx completed its Caliber trial and found it was more effective than omeprazole in controlling regurgitation and improving quality of life for patients with gastroesophageal reflux disease.
GI & Endoscopy
Enki Endoscopy Report Writer incorporated GIQuIC certification into its quality reporting platform.
The FDA granted accelerated approval to Keytruda, an adult and pediatric treatment for unresectable or metastatic solid tumors identified as having a biomarker.
AmSurg, Evolution Health and other industry-leading organizations gathered at a GI Research Summit, March 2 at Envision Healthcare's Nashville, Tenn. headquarters, to discuss how to study and leverage GIQuIC data in pursuit of Healthcare Quadruple Aim.
Here are four GI companies in the headlines from the past week.
Advertisement
Benjamin Schaus, DO, is a gastroenterologist at Buffalo (N.Y.) Gastroenterology Associates.
The Minnesota Safety Council recognized Takeda Pharmaceuticals for excellence in workplace safety.
A study published in the Annals of Internal Medicine examined interval colorectal cancer risks in minorities.
United Way of Northern New Jersey recognized Allergan for its positive impact in New Jersey over the last year, NJBiz.com reports.
A National Academy of Sciences, Engineering and Medicine report offers recommendations to eliminate approximately 90,000 hepatitis B and C-related deaths by 2030, Gastroenterology and Endoscopy News reports.